Schär Announces Second Annual Celiac Cruise Giveaway

FOR IMMEDIATE RELEASE

Win a Cabin on the 2025 Celiac Cruise Care of the Global Gluten-Free Brand and Enjoy a Worry-Free Experience of a Lifetime

Swedesboro, NJ / May 22, 2024 / (USANews.com) – Schär gluten-free food innovation leader, is thrilled to announce the launch of its second annual Celiac Cruise Giveaway. One lucky winner will receive a complimentary cabin on the 2025 Celiac Cruise, offering a worry-free vacation experience for individuals with celiac disease and gluten sensitivities.

The Celiac Cruise, in partnership with Royal Caribbean International, AMAWaterways, and Oceania Cruises, provides an unforgettable gluten-free vacation experience while fostering a supportive community of like-minded individuals. Guests can enjoy a variety of destinations around the world while indulging in delicious, gluten-free cuisine and participating in educational seminars led by experts in celiac disease management.

Schär’s Celiac Cruise giveaway aims to provide individuals with celiac disease the opportunity to enjoy a worry-free vacation where they can relax and indulge without fear of gluten exposure. Alongside the cruise, Schär is collaborating with several partners to generate awareness around celiac disease and create excitement about the participating brands. Partners include Celiac Cruise, Holidaily Brewing, Celiac Disease Foundation, Phil Hates Gluten, and Gluten Free Dave. The partnership aims to add contactable users to Schär’s CRM database while providing valuable resources and support to individuals living with celiac disease.

The Celiac Cruise offers a worry-free environment where guests can enjoy their vacation without the fear of gluten exposure. Cruising gluten-free has been a challenge for many individuals with celiac disease, but the Celiac Cruise aims to change that. Guests can indulge in delicious gluten-free meals prepared by experienced chefs and participate in a variety of onboard activities and entertainment options. Educational seminars led by experts provide valuable information on managing celiac disease while traveling.

The cruise is open to individuals with celiac disease, their families, and anyone interested in gluten-free travel. Guests can choose from a variety of destinations and itineraries, including Caribbean cruises, European river cruises, and Mediterranean voyages. Each cruise is carefully planned to ensure the safety and enjoyment of all guests, with special attention given to dietary restrictions and food allergies.

Entries for the Celiac Cruise Giveaway are open now, and one lucky winner will be randomly selected to receive a complimentary cabin on the 2025 Celiac Cruise. The official launch is scheduled to commence on May 1, 2024 and willing participants will be able to join by signing up on the official event page. The winner will be announced on June 4, 2024.

For more information about the Celiac Cruise Giveaway and to enter for a chance to win, visit the official event website.

For more information about Schär and the Celiac Cruise visit https://www.schaer.com/ and https://celiaccruise.com/.

About Schär

For more than 100 years, Dr. Schär’s mission has been to improve the lives of people with special nutritional needs. Dr. Schär USA, Inc. is committed to providing great-tasting gluten-free food to the celiac, gluten-sensitive sensitive and IBS communities—offering a safe, flavorful, and high-quality line of gluten-free products. Schär has over 20,000 doors in the US and retailers including Walmart, Kroger, Sprouts, Whole Foods, ShopRite, Stop & Shop, and many more. The full portfolio of products spans from bread, cookies, candy, and crackers to frozen items, including puff pastry dough and croissants! The new soy-free Artisan Baker Breads further solidifies the commitment to trust among consumers with food allergies.

Forward-Looking Statements

This release contains forward-looking statements regarding future operating and financial performance, product development, market position, and business strategy and objectives. These statements are based on current expectations of future events and are inherently subject to uncertainty. Actual results could vary materially from expectations and projections due to various factors. For a further list and description of these risks, uncertainties, and other factors, please refer to Dr. Schär’s filings with the SEC. Information in this release is as of the dates indicated herein, and Dr. Schär does not undertake to update any of the information contained in these materials, except as required by law.

For media inquiries and interview opportunities, please contact:
Heather Holmes
[email protected]
1+(828)332-5307

###